Abbott™ ID NOW™ COVID-19 2.0 24 Test Kit

Description

The ID NOW COVID-19 2.0 24 Test Kit helps clinicians to make faster decisions with diagnostic results in real time.

• CLIA-waived ID NOW™ COVID-19 2.0 assay delivers reliable molecular results in just minutes
• Gives real-time access to the information you need to make actionable decisions at the point of care
• Uses direct nasal or nasopharyngeal swabs
• Assay kit can be stored at room temperature and contains 24 tests, nasal swabs, and a positive control swab
• ID NOW Platform features bidirectional connectivity to support easy data integration from multiple instruments to hospital/lab information system.
• Positive results as early as 6 minutes, negative results in 12 minutes
• Nucleic Acid Amplification Technology (NAAT), providing molecular results in a fraction of the time it takes traditional lab tests
• Requires minimum training with easy on-screen steps to guide users
• You can decide which tests to run based on patient presentation, circulating prevalence and seasonality of infectious diseases

Specifications

• Certifications/Compliance: FDA 510(k)
• CE Marker: No
• Clia Complexity: Waived
• Detectable Analytes: SARS-CoV-2
• DoA Calibrators: No
• Sample Type: Nasal Swab, Nasopharyngeal Swab
• Type: COVID-19 Test Kit
• No. of Reactions: 24 Tests
• Quantity: 1 Kit
• Dimensions (L x W x H): 207 x 194 x 145 mm (8.2 x 7.6 x 5.7 in.)
• Form: Ready-to-Use (RTU)